Calibre Scientific has acquired Invitech Ltd., a UK-based supplier of in-vitro diagnostic products, to enhance its product offerings and strengthen its market presence in the life sciences sector.
Information on the Target
Invitech Ltd., based in the United Kingdom, specializes in the supply of in-vitro diagnostics and research kits tailored for clinical laboratories, contract research organizations (CROs), public institutions, and universities throughout the British Isles. The company offers a diverse range of products including HIV and HCV test kits, pregnancy tests, ELISA kits, Lyme Disease test kits (ViraChip), microbiology quality control slides, coagulation kits, and hematology stains, among others.
With a strong commitment to quality and innovation, Invitech Ltd. has established itself as a reputable supplier in the diagnostics field, contributing to accurate disease detection and management within the healthcare system.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the UK
The life sciences sector in the United Kingdom is one of the most advanced and dynamic in the world. The country boasts a strong research base, numerous world-class universities, and a thriving biopharmaceutical industry, which col
Similar Deals
Aya Healthcare → Locum’s Nest
2025
Foresight Group → MyWay Digital Health Ltd
2025
Keensight Capital → Bedfont Scientific
2025
Telemos Capital → Helios
2024
Calibre Scientific → Greyhound Chromatography and Allied Chemicals Ltd.
2024
Calibre Scientific
invested in
Invitech Ltd.
in 2024
in a Other Private Equity deal